News & Updates

Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
16 Oct 2024 byJairia Dela Cruz

In the treatment of patients with rifampicin-resistant tuberculosis (TB), two bedaquiline-containing regimens, namely a 9-month all-oral regimen and a shorter 6-month regimen with 8 weeks of aminoglycoside, maintains superior efficacy to a 9-month injectable regimen through 132 weeks, according to long-term data from the STREAM 2 trial.

Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
16 Oct 2024
Depression, anxiety tied to intragastric balloon intolerance, early removal
Depression, anxiety tied to intragastric balloon intolerance, early removal
16 Oct 2024 byStephen Padilla

Intragastric balloons (IGBs) are a less-invasive alternative to metabolic bariatric surgery (MBS) in the treatment of obesity and its complications, but many Asians suffer intolerance and have a higher rate of early balloon removal relative to Caucasians, reports a Singapore study. Moreover, both depression and anxiety are associated with early IGB removal.

Depression, anxiety tied to intragastric balloon intolerance, early removal
16 Oct 2024